Skip to main content
Daniel Rosenbluth, MD, Pulmonology, Saint Louis, MO

DanielBRosenbluthMD

Pulmonology Saint Louis, MO

Critical Care Medicine, Cystic Fibrosis, Interventional Pulmonology, Pleural Disease

Tracey C. and William J. Marshall Professor of Medicine, Washington University School of Medicine, St Louis, MO

Dr. Rosenbluth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenbluth's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 314-454-8917
    Fax+1 314-454-7524

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1989 - 1992
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1989

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1991 - 2026
  • MO State Medical License
    MO State Medical License 1994 - 2025
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • List of Temporary Practice Permits Granted May 5, 2020
    List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
  • New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering Patients
    New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering PatientsDecember 18th, 2019